Cargando…

Glycated Hemoglobin and the Risk of Kidney Disease and Retinopathy in Adults With and Without Diabetes

OBJECTIVE: Glycated hemoglobin was recently recommended for use as a diagnostic test for diabetes. We examined the association between 2010 American Diabetes Association diagnostic cut points for glycated hemoglobin and microvascular outcomes (chronic kidney disease, end-stage renal disease [ESRD],...

Descripción completa

Detalles Bibliográficos
Autores principales:	Selvin, Elizabeth, Ning, Yang, Steffes, Michael W., Bash, Lori D., Klein, Ronald, Wong, Tien Y., Astor, Brad C., Sharrett, A. Richey, Brancati, Frederick L., Coresh, Josef
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Complications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012185/ https://www.ncbi.nlm.nih.gov/pubmed/20978092 http://dx.doi.org/10.2337/db10-1198

Ejemplares similares

The Association of Hemoglobin A1c With Incident Heart Failure Among People Without Diabetes: The Atherosclerosis Risk in Communities Study
por: Matsushita, Kunihiro, et al.
Publicado: (2010)

Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality
por: Selvin, Elizabeth, et al.
Publicado: (2016)

Relationship of Glycated Albumin to Blood Glucose and HbA(1c) Values and to Retinopathy, Nephropathy, and Cardiovascular Outcomes in the DCCT/EDIC Study
por: Nathan, David M., et al.
Publicado: (2014)

No Racial Differences in the Association of Glycated Hemoglobin With Kidney Disease and Cardiovascular Outcomes
por: Selvin, Elizabeth, et al.
Publicado: (2013)

No Ethnic Differences in the Association of Glycated Hemoglobin With Retinopathy: The National Health and Nutrition Examination Survey 2005–2008
por: Bower, Julie K., et al.
Publicado: (2013)

New Diabetes Diagnostic Threshold of Hemoglobin A(1c) and the 3-Year Incidence of Retinopathy
por: Tsugawa, Yusuke, et al.
Publicado: (2012)

Performance of A1C for the Classification and Prediction of Diabetes
por: Selvin, Elizabeth, et al.
Publicado: (2011)

Glycated Hemoglobin and Risk of Hypertension in the Atherosclerosis Risk in Communities Study
por: Bower, Julie K., et al.
Publicado: (2012)

Pericyte Migration: A Novel Mechanism of Pericyte Loss in Experimental Diabetic Retinopathy
por: Pfister, Frederick, et al.
Publicado: (2008)

Association of Organochlorine Pesticides with Peripheral Neuropathy in Patients with Diabetes or Impaired Fasting Glucose
por: Lee, Duk-Hee, et al.
Publicado: (2008)

Heritability of Proliferative Diabetic Retinopathy
por: Hietala, Kustaa, et al.
Publicado: (2008)

Response to Comment on: Selvin et al. No Racial Differences in the Association of Glycated Hemoglobin With Kidney Disease and Cardiovascular Outcomes. Diabetes Care 2013;36:2995–3001
por: Selvin, Elizabeth, et al.
Publicado: (2013)

Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
por: Soro-Paavonen, Aino, et al.
Publicado: (2008)

Increased Expression and Activity of 12-Lipoxygenase in Oxygen-Induced Ischemic Retinopathy and Proliferative Diabetic Retinopathy: Implications in Retinal Neovascularization
por: Al-Shabrawey, Mohamed, et al.
Publicado: (2011)

Montelukast Prevents Early Diabetic Retinopathy in Mice
por: Bapputty, Reena, et al.
Publicado: (2019)

Does Genetic Ancestry Explain Higher Values of Glycated Hemoglobin in African Americans?
por: Maruthur, Nisa M., et al.
Publicado: (2011)

Glycation of LDL by Methylglyoxal Increases Arterial Atherogenicity: A Possible Contributor to Increased Risk of Cardiovascular Disease in Diabetes
por: Rabbani, Naila, et al.
Publicado: (2011)

Monosodium Urate Contributes to Retinal Inflammation and Progression of Diabetic Retinopathy
por: Thounaojam, Menaka C., et al.
Publicado: (2019)

Novel Detection and Restorative Levodopa Treatment for Preclinical Diabetic Retinopathy
por: Motz, Cara T., et al.
Publicado: (2020)

Retinal Arteriolar Dilation Predicts Retinopathy in Adolescents With Type 1 Diabetes
por: Cheung, Ning, et al.
Publicado: (2008)

Deletion of the Receptor for Advanced Glycation End Products Reduces Glomerulosclerosis and Preserves Renal Function in the Diabetic OVE26 Mouse
por: Reiniger, Nina, et al.
Publicado: (2010)

Role of Glyceraldehyde 3-Phosphate Dehydrogenase in the Development and Progression of Diabetic Retinopathy
por: Kanwar, Mamta, et al.
Publicado: (2009)

Epigenetic Changes in Mitochondrial Superoxide Dismutase in the Retina and the Development of Diabetic Retinopathy
por: Zhong, Qing, et al.
Publicado: (2011)

Therapeutic Potential of a Monoclonal Antibody Blocking the Wnt Pathway in Diabetic Retinopathy
por: Lee, Kyungwon, et al.
Publicado: (2012)

Skin Advanced Glycation End Products Glucosepane and Methylglyoxal Hydroimidazolone Are Independently Associated With Long-term Microvascular Complication Progression of Type 1 Diabetes
por: Genuth, Saul, et al.
Publicado: (2015)

Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes
por: Saulnier, Pierre-Jean, et al.
Publicado: (2016)

Quantitative Assessment of Early Diabetic Retinopathy Using Fractal Analysis
por: Cheung, Ning, et al.
Publicado: (2009)

Marrow-Derived Cells Regulate the Development of Early Diabetic Retinopathy and Tactile Allodynia in Mice
por: Li, Guangyuan, et al.
Publicado: (2012)

Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models
por: Chen, Ying, et al.
Publicado: (2013)

Hyperhexosemia-Induced Retinal Vascular Pathology in a Novel Primate Model of Diabetic Retinopathy
por: Chronopoulos, Argyrios, et al.
Publicado: (2015)

Plasma Exosomes Contribute to Microvascular Damage in Diabetic Retinopathy by Activating the Classical Complement Pathway
por: Huang, Chao, et al.
Publicado: (2018)

Pathogenic Role of microRNA-21 in Diabetic Retinopathy Through Downregulation of PPARα
por: Chen, Qian, et al.
Publicado: (2017)

Intervention With an Erythropoietin-Derived Peptide Protects Against Neuroglial and Vascular Degeneration During Diabetic Retinopathy
por: McVicar, Carmel M., et al.
Publicado: (2011)

Differentiating Microaneurysm Pathophysiology in Diabetic Retinopathy Through Objective Analysis of Capillary Nonperfusion, Inflammation, and Pericytes
por: An, Dong, et al.
Publicado: (2022)

Abrogation of MMP-9 Gene Protects Against the Development of Retinopathy in Diabetic Mice by Preventing Mitochondrial Damage
por: Kowluru, Renu A., et al.
Publicado: (2011)

MicroRNA-200b Regulates Vascular Endothelial Growth Factor–Mediated Alterations in Diabetic Retinopathy
por: McArthur, Kara, et al.
Publicado: (2011)

Liver X Receptor Modulates Diabetic Retinopathy Outcome in a Mouse Model of Streptozotocin-Induced Diabetes
por: Hazra, Sugata, et al.
Publicado: (2012)

Association of fasting insulin and C peptide with diabetic retinopathy in Latinos with type 2 diabetes
por: Kuo, Jane Z, et al.
Publicado: (2014)

Endothelial Progenitor Cells Carrying Monocyte Markers Are Selectively Abnormal in Type 1 Diabetic Patients With Early Retinopathy
por: Zerbini, Gianpaolo, et al.
Publicado: (2012)

Intravitreal AAV2.COMP-Ang1 Prevents Neurovascular Degeneration in a Murine Model of Diabetic Retinopathy
por: Cahoon, Judd M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ii3l7i7jblgb6epk15hepo86k3